Biomerica reports Q3 EPS ($1.20) vs ($1.90) last year

Reports Q3 revenue $1.1M vs $1M last year. “Our third quarter results reflect the meaningful progress we’ve made in strengthening our financial foundation while continuing to serve customers and grow our business,” said Zack Irani, CEO of Biomerica (BMRA). “We are particularly pleased with the significant reduction in our cash burn and operating expenses, which positions us well as we continue to focus on driving revenue growth and moving closer to achieving cash flow break-even.”